Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA stock opened at $0.00 on Wednesday. Calithera Biosciences has a 52 week low of $0.00 and a 52 week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.